Camurati-Engelmann disease

Print

Disease Overview

Camurati-Engelmann disease is a genetic condition that mainly affects the bones. People with this disease have increased bone density, particularly affecting the long bones of the arms and legs. In some cases, the skull and hip bones are also affected. The thickened bones can lead to pain in the arms and legs, a waddling walk, muscle weakness, and extreme tiredness. The age that symptoms begin varies greatly, but most people with this condition develop pain or weakness by adolescence.[376]

Camurati-Engelmann disease is caused by a mutation in the TGFB1 gene and inheritance is autosomal dominant.[376][377] In some cases, people have the gene mutation that causes Camurati-Engelmann disease but they never develop symptoms.[376] In others, symptoms are present, but a gene mutation cannot be found. These cases are referred to as Camurati-Engelmann disease type 2.[377]

Treatment for Camurati-Engelman disease depends on many factors including the signs and symptoms present in each person and the severity of the condition.[380] Treatment options  to control symptoms may include corticosteroid therapy, losartan as an adjuvant therapy to minimize the need for steroids, pain medications, and craniectomy to reduce intracranial pressure and headaches.[380]


Synonyms

  • CED
  • Diaphyseal dysplasia 1, progressive
  • DPD1
  • Engelmann disease
  • Progressive diaphyseal dysplasia
  • PDD

For more information, visit GARD.

National Organization for Rare Disorders